LIGAND PHARMACEUTICALS INC — Director's Dealing 2011

Mar 14, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2011-03-11

Reporting Person: LAMATTINA JOHN L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-03-11	Common Stock	P	1101	$9.729	Acquired	2767	Direct
2011-03-11	Common Stock	P	3899	$9.73	Acquired	6666	Direct
2011-03-11	Common Stock	P	3700	$9.875	Acquired	10366	Direct
2011-03-11	Common Stock	P	700	$9.879	Acquired	11066	Direct
2011-03-11	Common Stock	P	600	$9.88	Acquired	11666	Direct